
U.S. Pharmacogenomics Market Size to Achieve USD 5,676.1 Million by 2031, Fueled by a CAGR of 8.7%: Says AMR
Pharmacogenomics, also known as pharmacogenetics, is a branch of genomic medicine that uses a patient's genetic makeup to customize medications they receive. PORTLAND, OR, UNITED STATES, March 11, 2025 /EINPresswire.com/ -- The U.S. …